NAS
PRCT icon

Nykredit A/S’s Procept Biorobotics PRCT Stock Holding History

Nykredit A/S’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1K Buy
+1,199
New +$30K ﹤0.01% 1646

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Nykredit A/S's PRCT Position: Q2 2026 in Review

Nykredit A/S opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 1,199 shares worth $27.1K. The stake represents ﹤0.01% of the portfolio and ranks #1646 among its holdings.

183 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Nykredit A/S held 1,199 shares of Procept Biorobotics worth $27.1K as of Q2 2026.
  • Procept Biorobotics was a new Nykredit A/S position in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1646 holding.
  • 183 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.